{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:17:37Z","timestamp":1784546257836,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T00:00:00Z","timestamp":1625961600000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.psychres.2020.113279","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T10:58:54Z","timestamp":1593860334000},"page":"113279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Residual symptoms of PTSD following Sertraline plus enhanced medication management, Sertraline plus PE, and PE plus placebo"],"prefix":"10.1016","volume":"291","author":[{"given":"Jessica C.","family":"Tripp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya B.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Myra","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Venners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Martis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi M.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray B.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn B.","family":"Allard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila A.M.","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2020.113279_bib0001","unstructured":"American Psychological Association, 2017. Clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD), https:\/\/www.apa.org\/ptsd-guideline\/."},{"issue":"1","key":"10.1016\/j.psychres.2020.113279_bib0002","first-page":"75","article-title":"The development of a clinician-administered PTSD scale","volume":"8","author":"Blake","year":"1995","journal-title":"J. Trauma Stress"},{"issue":"2","key":"10.1016\/j.psychres.2020.113279_bib0003","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1037\/tra0000078","article-title":"Subthreshold posttraumatic stress disorder: a meta-analytic review of DSM-IV prevalence and a proposed DSM-5 approach to measurement","volume":"8","author":"Brancu","year":"2016","journal-title":"Psychol. Trauma"},{"issue":"12","key":"10.1016\/j.psychres.2020.113279_bib0004","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.brat.2013.09.008","article-title":"Change in sleep symptoms across cognitive processing therapy and prolonged exposure: a longitudinal perspective","volume":"51","author":"Gutner","year":"2013","journal-title":"Behav. Res. Ther."},{"issue":"3","key":"10.1016\/j.psychres.2020.113279_bib0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1037\/pst0000231","article-title":"A guide to guidelines for the treatment of posttraumatic stress disorder in adults: an update","volume":"56","author":"Hamblen","year":"2019","journal-title":"Psychotherapy"},{"issue":"2","key":"10.1016\/j.psychres.2020.113279_bib0006","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/tra0000384","article-title":"Residual symptoms following empirically supported treatment for PTSD","volume":"11","author":"Larsen","year":"2019","journal-title":"Psychol. Trauma"},{"issue":"6","key":"10.1016\/j.psychres.2020.113279_bib0007","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cpr.2014.06.002","article-title":"Client preferences affect treatment satisfaction, completion, and clinical outcome: a meta-analysis","volume":"34","author":"Lindhiem","year":"2014","journal-title":"Clin. Psychol. Rev."},{"issue":"9","key":"10.1016\/j.psychres.2020.113279_bib0008","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1176\/appi.ajp.158.9.1467","article-title":"Comorbidity, impairment, and suicidality in subthreshold PTSD","volume":"158","author":"Marshall","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2020.113279_bib0009","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1037\/neu0000312","article-title":"Sleep quality affects cognitive functioning in returning combat veterans beyond combat exposure, PTSD, and mild TBI history","volume":"31","author":"Martindale","year":"2017","journal-title":"Neuropsychology"},{"issue":"3","key":"10.1016\/j.psychres.2020.113279_bib0010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1037\/a0026636","article-title":"Anger and postcombat mental health: Validation of a brief anger measure with U.S. Soldiers post deployed from Iraq and Afghanistan","volume":"24","author":"Novaco","year":"2012","journal-title":"Psychol. Assess."},{"issue":"6","key":"10.1016\/j.psychres.2020.113279_bib0011","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1037\/tra0000150","article-title":"Residual sleep disturbances following PTSD treatment in active duty military personnel","volume":"8","author":"Pruiksma","year":"2016","journal-title":"Psychol. Trauma"},{"issue":"2","key":"10.1016\/j.psychres.2020.113279_bib0012","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamapsychiatry.2018.3412","article-title":"Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial","volume":"76","author":"Rauch","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2020.113279_bib0013","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cct.2017.10.013","article-title":"Integrating biological treatment mechanisms into randomized clinical trials: design of PROGrESS (PROlonGed ExpoSure and Sertraline Trial)","volume":"64","author":"Rauch","year":"2018","journal-title":"Contemp. Clin. Trials"},{"issue":"6","key":"10.1016\/j.psychres.2020.113279_bib0014","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1037\/ccp0000031","article-title":"Differential effects of prolonged exposure on posttraumatic stress disorder symptoms in female veterans","volume":"83","author":"Schnurr","year":"2015","journal-title":"J. Consult. Clin. Psychol."},{"issue":"3","key":"10.1016\/j.psychres.2020.113279_bib0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/da.22477","article-title":"Symptom benchmarks of improved quality of life in PTSD","volume":"33","author":"Schnurr","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psychres.2020.113279_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/da.22871","article-title":"Frontline science: residual symptoms following prolonged exposure and present\u2010centered therapy for PTSD in female veterans and soldiers","author":"Schnurr","year":"2019","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psychres.2020.113279_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/jts.22552","article-title":"Residual symptoms of PTSD and AUD following integrated exposure treatment versus coping skills treatment","author":"Tripp","year":"2020","journal-title":"J. Trauma Stress"},{"key":"10.1016\/j.psychres.2020.113279_bib0018","unstructured":"VA\/DOD, 2017. Clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder, https:\/\/www.healthquality.va.gov\/guidelines\/MH\/ptsd\/VADoDPTSDCPGFinal012418.pdf."},{"issue":"3","key":"10.1016\/j.psychres.2020.113279_bib0019","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1037\/pas0000486","article-title":"The clinician-administered PTSD scale for DSM-5 (CAPS-5): development and initial psychometric evaluation in military veterans","volume":"30","author":"Weathers","year":"2018","journal-title":"Psychol. Assess."},{"issue":"3","key":"10.1016\/j.psychres.2020.113279_bib0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/da.1029","article-title":"Clinician-administered PTSD scale: a review of the first ten years of research","volume":"13","author":"Weathers","year":"2001","journal-title":"Depress. Anxiety"},{"issue":"11","key":"10.1016\/j.psychres.2020.113279_bib0021","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v028.i11","article-title":"Exact tests for two-way contingency tables with structural zeros","volume":"28","author":"West","year":"2008","journal-title":"J. Stat. Softw."},{"issue":"9","key":"10.1016\/j.psychres.2020.113279_bib0022","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/jamainternmed.2015.3006","article-title":"Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis","volume":"175","author":"Wu","year":"2015","journal-title":"JAMA Intern. Med."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178120313925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178120313925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:48:21Z","timestamp":1759038501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178120313925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":22,"alternative-id":["S0165178120313925"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113279","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual symptoms of PTSD following Sertraline plus enhanced medication management, Sertraline plus PE, and PE plus placebo","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113279"}}